{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.46","value":"1.39"},{"groupId":"OG001","spread":"20.52","value":"2.32"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"126"},{"groupId":"OG001","value":"115"}],"units":"Participants"}],"title":"Week 7"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.91","value":"1.49"},{"groupId":"OG001","spread":"16.33","value":"3.81"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"95"},{"groupId":"OG001","value":"59"}],"units":"Participants"}],"title":"Week 13"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.58","value":"3.07"},{"groupId":"OG001","spread":"17.16","value":"3.15"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"87"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Week 19"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.25","value":"3.52"},{"groupId":"OG001","spread":"21.28","value":"-0.76"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"71"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Week 25"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.46","value":"2.53"},{"groupId":"OG001","spread":"17.83","value":"4.17"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Week 31"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.61","value":"3.26"},{"groupId":"OG001","spread":"18.45","value":"7.14"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"14"}],"units":"Participants"}],"title":"Week 37"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.24","value":"1.69"},{"groupId":"OG001","spread":"18.06","value":"-1.04"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"8"}],"units":"Participants"}],"title":"Week 43"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.95","value":"4.31"},{"groupId":"OG001","spread":"13.94","value":"3.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"60"},{"groupId":"OG001","value":"5"}],"units":"Participants"}],"title":"Week 49"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.26","value":"2.92"},{"groupId":"OG001","spread":"23.42","value":"12.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Week 55"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.72","value":"1.79"},{"groupId":"OG001","spread":"17.35","value":"13.89"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"3"}],"units":"Participants"}],"title":"Week 61"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.92","value":"2.08"},{"groupId":"OG001","spread":"11.79","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 67"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.10","value":"4.69"},{"groupId":"OG001","spread":"5.89","value":"12.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 73"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.84","value":"5.62"},{"groupId":"OG001","spread":"11.79","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"46"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 79"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.43","value":"3.05"},{"groupId":"OG001","spread":"5.89","value":"12.50"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 85"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.92","value":"3.66"},{"groupId":"OG001","spread":"0.00","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 91"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.48","value":"4.27"},{"groupId":"OG001","spread":"11.79","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 97"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.56","value":"6.20"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 103"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.75","value":"3.83"},{"groupId":"OG001","spread":"11.79","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"2"}],"units":"Participants"}],"title":"Week 109"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.15","value":"4.17"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 115"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.25","value":"1.47"},{"groupId":"OG001","spread":"0.00","value":"0.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 121"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"19.91","value":"-0.26"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 127"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.09","value":"3.16"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 133"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.86","value":"1.11"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 139"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.07","value":"4.69"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 145"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.34","value":"1.67"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 151"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.99","value":"3.53"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 157"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.83","value":"7.94"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 163"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"17.61","value":"13.33"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 169"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.66","value":"7.84"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"50.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 175"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.16","value":"5.42"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 181"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"22.06","value":"1.85"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 187"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.96","value":"2.50"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 193"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.13","value":"6.77"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 199"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.07","value":"0.93"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 205"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"18.97","value":"0.49"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 211"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.32","value":"1.19"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 217"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.49","value":"5.26"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 223"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.77","value":"5.56"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 229"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.82","value":"5.39"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 235"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.72","value":"2.78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 241"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.45","value":"5.36"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 247"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.89","value":"3.89"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 253"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.26","value":"7.05"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"25.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 259"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.55","value":"8.93"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 265"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.94","value":"6.25"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 271"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.12","value":"4.17"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"25.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 277"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"21.42","value":"5.56"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 283"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"20.86","value":"3.57"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 289"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.15","value":"3.47"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 295"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"23.92","value":"2.78"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 301"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.95","value":"1.52"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 307"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"24.04","value":"9.17"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 313"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.70","value":"3.33"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 319"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"25.37","value":"9.38"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 325"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"27.09","value":"10.71"},{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG001","spread":"NA","value":"33.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"Week 331"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.29","value":"11.90"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 337"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.35","value":"16.67"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 343"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"26.54","value":"9.52"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 349"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.21","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 355"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"30.81","value":"20.83"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 361"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"36.32","value":"25.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 367"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"36.32","value":"25.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 373"},{"categories":[{"measurements":[{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 379"},{"categories":[{"measurements":[{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 385"},{"categories":[{"measurements":[{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 391"},{"categories":[{"measurements":[{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 397"},{"categories":[{"measurements":[{"comment":"Insufficient number of participants to calculate standard deviation","groupId":"OG000","spread":"NA","value":"8.33"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"Week 403"}],"denoms":[{"counts":[{"groupId":"OG000","value":"210"},{"groupId":"OG001","value":"208"}],"units":"Participants"}],"description":"HRQoL is evaluated by mean changes from baseline in the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) global health status/quality of life composite scale in all randomized patients. The QLQ-30 is a cancer-specific, self-administered questionnaire that contains 30 questions, covering global, functional, and symptom scales. Scores range from 0 to 100. Higher scores on global and functional scales indicate better quality of life (QoL), while higher scores on the symptom scales indicate declining QoL.","dispersionType":"Standard Deviation","groups":[{"description":"Participants received nivolumab, 3 mg/kg, solution administered Intravenously (IV) every 2 weeks with placebo-matching dacarbazine solution administered IV every 3 weeks, until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion","id":"OG000","title":"Nivolumab, 3 mg/kg + Placebo-matching Dacarbazine"},{"description":"Participants received dacarbazine 1000 mg/m\\^2, solution administered IV every 3 weeks with placebo-matching nivolumab solution administered IV every 2 weeks until disease progression, discontinuation due to toxicity, withdrawal of consent, or study completion","id":"OG001","title":"Dacarbazine, 1000 mg/m^2 + Placebo-matching Nivolumab"}],"paramType":"MEAN","populationDescription":"All randomized participants with available measurements","reportingStatus":"POSTED","timeFrame":"At baseline and every 6 weeks for 12 months and at follow-up visits 1 and 2, assessed up to 93 months","title":"Change From Baseline in Health-related Quality of Life (HRQoL) Scores","type":"SECONDARY","unitOfMeasure":"Units on a scale"}